Lilly Korea does not consider Zuellig Korea as outsourcing partner

Published: 2003-05-16 06:59:00

Updated: 2003-05-16 06:59:00

An official from Lilly Korea, affiliated company of a U.S.-based multinational firm, has dismissed the recent rumor that it is moving toward Zuellig Korea as outsourcing partner, saying that the company has reviewed this matter for a couple of years as part of handling ex post facto business in a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK